Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma

Reference

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74 - 108; http://dx.doi.org/10.3322/canjclin.55.2.74; PMID: 15761078
   PubMed Web of Science ®Google Scholar
• De Flora S, Bonanni P. The prevention of infection-associated cancers. Carcinogenesis 2011; 32:787 - 95; http://dx.doi.org/10.1093/carcin/bgr054; PMID: 21436188
   PubMed Web of Science ®Google Scholar
• Leong TY, Leong AS. Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) 2005; 7:5 - 15; http://dx.doi.org/10.1080/13651820410024021; PMID: 18333156
   PubMedGoogle Scholar
• Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G. Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009; 15:3210 - 6; http://dx.doi.org/10.3748/wjg.15.3210; PMID: 19598295
   PubMed Web of Science ®Google Scholar
• Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: A population-based case-control study. Hepatology 2011; 54:463 - 71; http://dx.doi.org/10.1002/hep.24397; PMID: 21538440
   PubMed Web of Science ®Google Scholar
• Han KH, Seong J, Kim JK, Ahn SH, Lee Y, Chon CY. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008; 113:995 - 1003; http://dx.doi.org/10.1002/cncr.23684; PMID: 18615601
   PubMed Web of Science ®Google Scholar
• Morise Z, Sugioka A, Fujita J, Hoshimoto S, Kato T, Ikeda M. S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas. Hepatogastroenterology 2007; 54:2315 - 8; PMID: 18265655
   PubMed Web of Science ®Google Scholar
• Ye CG, Wu WK, Yeung JH, Li HT, Li ZJ, Wong CC, et al. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression. Cancer Lett 2011; 304:90 - 6; http://dx.doi.org/10.1016/j.canlet.2011.01.025; PMID: 21377266
   PubMed Web of Science ®Google Scholar
• Fujii R, Mutoh M, Niwa K, Yamada K, Aikou T, Nakagawa M, et al. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn J Cancer Res 1994; 85:426 - 33; http://dx.doi.org/10.1111/j.1349-7006.1994.tb02376.x; PMID: 8200854
   PubMedGoogle Scholar
• Lai GM, Ozols RF, Young RC, Hamilton TC. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J Natl Cancer Inst 1989; 81:535 - 9; http://dx.doi.org/10.1093/jnci/81.7.535; PMID: 2493524
   PubMed Web of Science ®Google Scholar
• Chaney SG, Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 1996; 88:1346 - 60; http://dx.doi.org/10.1093/jnci/88.19.1346; PMID: 8827012
   PubMed Web of Science ®Google Scholar
• Sedletska Y, Giraud-Panis MJ, Malinge JM. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents 2005; 5:251 - 65; http://dx.doi.org/10.2174/1568011053765967; PMID: 15992353
   PubMedGoogle Scholar
• Zhu AX, El-Khoueiry A, Llovet JM. Accomplishments in 2008 in the management of hepatobiliary cancers. Gastrointest Cancer Res 2009; 3:Supplement 2 S28 - 36; PMID: 20011562
   PubMedGoogle Scholar
• Wang Q, Zheng XL, Yang L, Shi F, Gao LB, Zhong YJ, et al. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res 2010; 29:159; http://dx.doi.org/10.1186/1756-9966-29-159; PMID: 21143894
   PubMed Web of Science ®Google Scholar
• Rutkowski DT, Kaufman RJ. All roads lead to ATF4. Dev Cell 2003; 4:442 - 4; http://dx.doi.org/10.1016/S1534-5807(03)00100-X; PMID: 12689582
   PubMed Web of Science ®Google Scholar
• Armstrong JL, Flockhart R, Veal GJ, Lovat PE, Redfern CP. Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells. J Biol Chem 2010; 285:6091 - 100; http://dx.doi.org/10.1074/jbc.M109.014092; PMID: 20022965
   PubMed Web of Science ®Google Scholar
• Ameri K, Hammond EM, Culmsee C, Raida M, Katschinski DM, Wenger RH, et al. Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene 2007; 26:284 - 9; http://dx.doi.org/10.1038/sj.onc.1209781; PMID: 16847457
   PubMed Web of Science ®Google Scholar
• Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005; 24:3470 - 81; http://dx.doi.org/10.1038/sj.emboj.7600777; PMID: 16148948
   PubMed Web of Science ®Google Scholar
• Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 2008; 68:152 - 61; http://dx.doi.org/10.1158/0008-5472.CAN-07-2126; PMID: 18172307
   PubMed Web of Science ®Google Scholar
• Tanabe M, Izumi H, Ise T, Higuchi S, Yamori T, Yasumoto K, et al. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. Cancer Res 2003; 63:8592 - 5; PMID: 14695168
   PubMed Web of Science ®Google Scholar
• Igarashi T, Izumi H, Uchiumi T, Nishio K, Arao T, Tanabe M, et al. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 2007; 26:4749 - 60; http://dx.doi.org/10.1038/sj.onc.1210289; PMID: 17297441
   PubMed Web of Science ®Google Scholar
• Ameri K, Lewis CE, Raida M, Sowter H, Hai T, Harris AL. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells. Blood 2004; 103:1876 - 82; http://dx.doi.org/10.1182/blood-2003-06-1859; PMID: 14604972
   PubMed Web of Science ®Google Scholar
• Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11:619 - 33; http://dx.doi.org/10.1016/S1097-2765(03)00105-9; PMID: 12667446
   PubMed Web of Science ®Google Scholar
• Namba T, Hoshino T, Tanaka K, Tsutsumi S, Ishihara T, Mima S, et al. Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells. Mol Pharmacol 2007; 71:860 - 70; http://dx.doi.org/10.1124/mol.106.027698; PMID: 17167033
   PubMed Web of Science ®Google Scholar
• Shringarpure R, Catley L, Bhole D, Burger R, Podar K, Tai YT, et al. Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib. Br J Haematol 2006; 134:145 - 56; http://dx.doi.org/10.1111/j.1365-2141.2006.06132.x; PMID: 16846475
   PubMed Web of Science ®Google Scholar
• Niedner H, Christen R, Lin X, Kondo A, Howell SB. Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 2001; 60:1153 - 60; PMID: 11723219
   PubMed Web of Science ®Google Scholar
• Selvakumaran M, Pisarcik DA, Bao R, Yeung AT, Hamilton TC. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 2003; 63:1311 - 6; PMID: 12649192
   PubMed Web of Science ®Google Scholar
• Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, et al. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 2004; 279:23477 - 85; http://dx.doi.org/10.1074/jbc.M313709200; PMID: 15026414
   PubMed Web of Science ®Google Scholar
• Garrido N, Pérez-Martos A, Faro M, Lou-Bonafonte JM, Fernández-Silva P, López-Pérez MJ, et al. Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels. Biochem J 2008; 414:93 - 102; http://dx.doi.org/10.1042/BJ20071615; PMID: 18426391
   PubMed Web of Science ®Google Scholar
• Choy CS, Cheah KP, Chiou HY, Li JS, Liu YH, Yong SF, et al. Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration. J Appl Toxicol 2008; 28:945 - 56; http://dx.doi.org/10.1002/jat.1360; PMID: 18548746
   PubMed Web of Science ®Google Scholar
• Grant CE, Gao M, DeGorter MK, Cole SP, Deeley RG. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab Dispos 2008; 36:2571 - 81; http://dx.doi.org/10.1124/dmd.108.022491; PMID: 18775981
   PubMed Web of Science ®Google Scholar
• Fung H, Liu P, Demple B. ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis. Mol Cell Biol 2007; 27:8834 - 47; http://dx.doi.org/10.1128/MCB.00974-07; PMID: 17938202
   PubMed Web of Science ®Google Scholar